Canakinumab not for heart attack prevention : FDA Vinay Singh singh21 Oct 2018 8:10 PM ISTThe U.S Food and Drug Administration has rejected to approve canakinumab for cardiovascular risk reduction, according to the Swiss drugmaker Novartis....
Entacapone use not associated with increased risk of prostate cancer, confirms FDA Deepanjana Sarkar18 Aug 2019 7:10 PM ISTThe U.S Food and Drug Administration (FDA) has recently made a safety announcement regarding a commonly used medication for Parkinson's disease,...
Secukinumab OK for treatment of axial spondyloarthritis: Findings from PREVENT Trial Dr. Kamal Kant Kohli Kohli6 Oct 2019 7:28 PM ISTDelhi: Findings from phase 3 PREVENT trial supports the use of secukinumab (Cosentyx) for the treatment of non-radiographic axial spondyloarthritis...
FDA approves brolucizumab injection for treatment of neovascular AMD Dr. Kamal Kant Kohli Kohli10 Oct 2019 7:25 PM ISTThe Food and Drug Administration has approved brolucizumab injection for the treatment of neovascular or wet age-related macular degeneration (AMD)....
Secukinumab protects damage to Joints in Psoriatic Arthritis Vinay Singh singh22 Jun 2018 7:10 PM ISTThe Food and Drug Administration (FDA) has approved the inclusion of new evidence that Cosentyx®(secukinumab) significantly slows the progression of...
